%0 Journal Article
%T Urinary levels of Hepatocarcinoma-intestine-pancreas/Pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer
%A Yujiro Nitta
%A Hiroyuki Konishi
%A Tetsuya Makino
%A Tomoaki Tanaka
%A Hidenori Kawashima
%A Juan L Iovanna
%A Tatsuya Nakatani
%A Hiroshi Kiyama
%J BMC Urology
%D 2012
%I BioMed Central
%R 10.1186/1471-2490-12-24
%X HIP/PAP expression in BCa samples was evaluated by western blot analysis, and urinary levels of HIP/PAP in patients with BCa were measured by enzyme-linked immunosorbent assay. Urine samples were collected from 10 healthy volunteers and 109 with benign urological disorders as controls, and from 101 patients who were diagnosed with BCa.HIP/PAP was highly expressed in BCa samples as compared with control bladder. Urinary HIP/PAP concentrations were significantly higher in BCa patients than in controls (median value; 3.184£¿pg/mL vs. 55.200£¿pg/mL, P <0.0001, by Mann¨CWhitney U test). Urinary HIP/PAP levels in BCa patients correlated positively with pathological T stages and progression-risk groups among non-muscle invasive BCa (P£¿=£¿0.0008, by Kruskal-Wallis test). Regarding the recurrence-risk classifications of non-muscle invasive BCa, the urinary levels of HIP/PAP were significantly higher in the intermediate than in the low risk group (P£¿=£¿0.0002, by Mann¨CWhitney U test). Based on a cut-off of 8.5£¿pg/mL, the ability of urinary HIP/PAP levels to detect BCa had a sensitivity of 80.2%, specificity of 78.2%, positive predictive value (PPV) of 75.7%, and negative predictive value (NPV) of 82.3%.HIP/PAP was abundantly expressed in BCa, and the urinary levels of HIP/PAP could be a novel and potent biomarker for detection of BCa, and also for predicting the risks of recurrence- and progression-risk of non-muscle invasive BCa. A large scale study will be needed to establish the usefulness of this biomarker.Urothelial carcinoma is the most common Bladder cancer (BCa). In 2008, an estimated 38,6300 cases were newly diagnosed with bladder cancer and there were 150,200 deaths due to bladder cancer worldwide. [1] Early detection of primary and recurrent bladder cancers may greatly reduce the mortality rate. The cystoscopic examination is a feasible procedure for detection of BCa. However, the examination is invasive for patients. On the other hand, urine cytology is the most widesp
%K Bladder cancer
%K Urinary marker
%K HIP/PAP
%K ELISA
%K ROC
%U http://www.biomedcentral.com/1471-2490/12/24